Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2014
05/27/2014US8735553 Anti-PD1 antibodies and their use as therapeutics and diagnostics
05/27/2014US8735552 Generation, expression and characterization of the humanized K33N monoclonal antibody
05/27/2014US8735551 Antibodies for epidermal growth factor receptor 3 (HER3)
05/27/2014US8735548 Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof
05/27/2014US8735547 Optimized Fc Variants
05/27/2014US8735546 Dual variable domain immunoglobulins and uses thereof
05/27/2014US8735545 Fc variants having increased affinity for fcyrllc
05/27/2014US8735360 Treatments for gastrointestinal disorders
05/27/2014US8734854 Process for removing growth factors from platelets
05/27/2014US8734812 Neisserial antigenic peptides
05/27/2014US8734802 Methods of treating vasomotor symptoms using antibodies
05/27/2014US8734801 Anti-IL13 antibodies and uses thereof
05/27/2014US8734800 Subtypes of humanized antibody against interleukin-6 receptor
05/27/2014US8734798 Function modifying NAv 1.7 antibodies
05/27/2014US8734797 Anti-IL13 antibodies and uses thereof
05/27/2014US8734796 Carrier immunoglobulins
05/27/2014US8734795 Light targeting molecules and uses thereof
05/27/2014US8734794 Humanised antibodies to toll-like receptor 2 and uses thereof
05/27/2014US8734792 Reagents and treatment methods for autoimmune diseases
05/27/2014US8734791 Optimized fc variants and methods for their generation
05/27/2014US8734790 Anti-TLR4 antibodies and methods of use thereof
05/27/2014US8734789 Targets for regulation of angiogenesis
05/27/2014US8734788 Composition and method for treatment of reperfusion injury and tissue damage
05/27/2014CA2638799C Cd86 and cd80 receptor competition assays
05/27/2014CA2625992C Inhibition of placenta growth factor (p1gf) mediated metastasis and/or angiogenesis
05/27/2014CA2611816C Methods of purifying fc region containing proteins
05/27/2014CA2597255C Natural ligand of g protein coupled receptor rcc356 and uses thereof
05/27/2014CA2564989C Reducing the risk of human and anti-human antibodies through v gene manipulation
05/27/2014CA2562024C Methods for treating bone cancer pain by administering a nerve growth factor antagonist
05/27/2014CA2525243C Use of melanotransferrin (p97) for regulating plasminogen activation and cell migration
05/27/2014CA2508375C Antibodies directed to tumor necrosis factor and uses thereof
05/27/2014CA2482138C La1 - the genome of a lactobacillus strain
05/27/2014CA2406033C Anti-d monoclonal antibodies
05/27/2014CA2343335C Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
05/27/2014CA2298855C Interleukin-18 binding proteins, their preparation and use
05/22/2014WO2014078866A2 Engineered immunoglobulins with extended in vivo half-life
05/22/2014WO2014078503A1 Methods of treating ovarian cancer with dll4 antagonists
05/22/2014WO2014078502A1 Use of il-1 beta binding antibodies for treating peripheral arterial disease
05/22/2014WO2014078475A2 Recombinant cell surface capture proteins
05/22/2014WO2014078373A1 Antimicrobial compositions
05/22/2014WO2014078306A1 Anti-prokineticin receptor (prokr) antibodies and uses thereof
05/22/2014WO2014078280A1 Enrichment of antigen-specific plasmablasts
05/22/2014WO2014077777A1 Monoclonal antibodies targeting neutralizing epitopes on h7 influenza viruses
05/22/2014WO2014077648A1 Antibody binding specifically to human and mouse l1cam protein, and use therefor
05/22/2014WO2014076292A1 Recombinant bispecific antibody binding to cd20 and cd95
05/22/2014WO2014076179A1 New polypeptide
05/22/2014WO2014076177A1 New polypeptide
05/22/2014WO2014075788A1 Agents for treatment of claudin expressing cancer diseases
05/22/2014WO2014075697A1 Agents for treatment of claudin expressing cancer diseases
05/22/2014WO2014075576A1 Humanized anti-human epidemic growth factor receptor antibody and encoding gene and application thereof
05/22/2014WO2014015091A3 Bovine influenza c virus compositions
05/22/2014WO2013037484A8 ANTI-αβTCR ANTIBODY
05/22/2014WO2011139974A9 Anti-pai-1 antibodies and methods of use thereof
05/22/2014US20140142286 Cell culture process
05/22/2014US20140141508 Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides
05/22/2014US20140141507 Method for the production of immunoglobulin single variable domains
05/22/2014US20140141506 Vectors, Host Cells, and Methods of Production and Uses
05/22/2014US20140141484 Multiple Hybrid Immunoassay
05/22/2014US20140141468 Bacterial host strain expressing recombinant dsbc
05/22/2014US20140141454 Monoclonal antibody to human epithelial cell adhesion molecule and method for detecting circulating tumor cells using the same
05/22/2014US20140141451 Assay to determine lrrk2 activity in parkinson's disease
05/22/2014US20140141445 Isolated Mammalian Monocyte Cell Genes; Related Reagents
05/22/2014US20140141444 Isolated Mammalian Monocyte Cell Genes; Related Reagents
05/22/2014US20140141093 Polypeptides, antibody variable domains and antagonists
05/22/2014US20140141031 Pathogenic bacteria
05/22/2014US20140141023 Novel antigen binding protein and its use as addressing product for the treatment of cancer
05/22/2014US20140141022 Single-chain multivalent binding proteins with effector function
05/22/2014US20140141021 Method for preparing a concentrate of polyvalent immunoglobulin
05/22/2014US20140141019 Antibodies against her3
05/22/2014US20140141018 Antagonist anti-il-7 receptor antibodies and methods
05/22/2014US20140141016 Antibodies to cd70
05/22/2014US20140141015 QSOX1 as an Anti-Neoplastic Drug Target
05/22/2014US20140141014 Antibodies that inhibit metalloproteins
05/22/2014US20140141013 Anti-il-6 antibodies, compositions, methods and uses
05/22/2014US20140141012 Engineered anti-tslp antibody
05/22/2014US20140141011 Engineered anti-tslp antibody
05/22/2014US20140141009 Use of antagonists targeting metallothionein to treat intestinal inflammation
05/22/2014US20140141008 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
05/22/2014US20140141007 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
05/22/2014US20140141006 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
05/22/2014US20140141004 Immunogenic peptides and methods of use for treating and preventing cancer
05/22/2014US20140141003 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
05/22/2014US20140141002 Method for Inhibiting Cellular Activation by Insulin-Like Growth Factor-1
05/22/2014US20140141001 Anit-Human Interleukin-20 Antibodies
05/22/2014US20140141000 Bispecific EGFR/C-Met Antibodies
05/22/2014US20140140999 Methods and means for the production of ig-like molecules
05/22/2014US20140140998 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
05/22/2014US20140140997 Methods of Treating Retroviral Infections in Felines
05/22/2014US20140140996 Anti-serum albumin biding variable domains
05/22/2014US20140140990 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
05/22/2014US20140140989 Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
05/22/2014US20140140954 Methods of modulating cytokine activity; related reagents
05/22/2014US20140140933 Anti-complement c1s antibodies and uses thereof
05/22/2014US20140140924 Humanized L243 Antibodies
05/22/2014DE10111224B4 Analoge der Ecstasy-Klasse sowie Verwendung derselben beim Nachweis von Verbindungen der Ecstasy-Klasse Analog ecstasy-class and use thereof in the detection of compounds of ecstasy-class
05/21/2014EP2733153A1 Methods for the preparation of immunoconjugates and uses thereof
05/21/2014EP2732289A2 Antibodies, kit and method for detecting amyloid beta oligomers
05/21/2014EP2732036A2 Compositions comprising agents that inhibit neuropilin and tolloid like 2
05/21/2014EP2731973A1 Bacterial host strain expressing recombinant dsbc
05/21/2014EP2731972A1 Anti-folate receptor alpha antibodies and uses thereof
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 1494